[HTML][HTML] Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands

…, EAM Sanders, K Elberse, BJ Vlaminckx… - Emerging infectious …, 2015 - ncbi.nlm.nih.gov
Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent
pneumococcal conjugate vaccine in the Netherlands, we observed a decrease in incidence …

Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease

SMT Vestjens, EAM Sanders, BJ Vlaminckx… - Vaccine, 2019 - Elsevier
Introduction In 2006, the Netherlands introduced the 7-valent pneumococcal conjugate vaccine
(PCV7) in their national immunisation programme. In 2011, PCV7 was replaced by the 10…

Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2–6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to …

GHJ Wagenvoort, EAM Sanders, BJ Vlaminckx… - Vaccine, 2016 - Elsevier
Background Implementation of 7-valent pneumococcal conjugate vaccine (PCV7) in the
Dutch national immunization program for infants led to a shift from vaccine to non-vaccine …

Long-term mortality after IPD and bacteremic versus non-bacteremic pneumococcal pneumonia

…, HE de Melker, A van der Ende, BJ Vlaminckx… - Vaccine, 2017 - Elsevier
Background Short-term mortality after invasive pneumococcal disease (IPD) and pneumococcal
pneumonia is high but data on long-term mortality (including the comparison between …

[HTML][HTML] Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015

…, EAM Sanders, BJ Vlaminckx… - …, 2017 - eurosurveillance.org
… Gertjan HJ Wagenvoort 1 ; Elisabeth AM Sanders 2 3 ; Bart J Vlaminckx 1 ; Hester E de Melker
… de Melker, Bart Vlaminckx. Drafting manuscript, interpretation of data and serotyping: Arie …

Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands

…, MJ Knol, HE de Melker, BJ Vlaminckx… - Vaccine, 2016 - Elsevier
Background Immunocompromising conditions and advanced age (≥65 years) are associated
with a high risk for invasive pneumococcal disease (IPD). We investigated the risk and …

Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients

…, H van Velzen-Blad, BJ Vlaminckx… - European journal of …, 2011 - Springer
The purpose of this study was to determine the quantity and quality of antibodies against the
meningococcal serogroup C (MenC) conjugated vaccine in asplenic patients. In 116 …

Prevalence of antibiotic resistance of the commensal flora in Dutch nursing homes

…, EE Stobberingh, SV van Rossum, BJ Vlaminckx… - Journal of the American …, 2013 - Elsevier
OBJECTIVES: To determine the prevalence of antibiotic resistance and multiresistance of
Escherichia coli and Staphylococcus aureus in nursing homes and to determine which factors …

Invasive Lancefield group A streptococcal infections in the Netherlands

BJ Vlaminckx, EM Mascini… - Nederlands Tijdschrift …, 2007 - europepmc.org
After a steady decrease in morbidity and mortality resulting from severe group A streptococcal
(GAS) infections, the 1980s witnessed a resurgence of invasive GAS disease. As a result a …

The Dutch MRSA policy should be retained

BJ Vlaminckx, A Troelstra… - Nederlands Tijdschrift …, 2006 - europepmc.org
The Dutch methicillin-resistant Staphylococcus aureus (MRSA)'search and destroy'policy is
effective. MRSA should be banned from hospitals: MRSA infections are associated with …